4-aminobenzoate 500 MG Oral Capsule [Potaba]

RxNorm concept 202088, branded drug (sbd). Prescribable name: POTABA 500 MG Oral Capsule.

RxCUI: 202088
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/202088 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

4-aminobenzoate 618974

Other names

Potaba 0.5 GM Oral Capsule; Potaba 500 MG Oral Capsule

Related concepts

4-aminobenzoate 500 MG (SCDC, consists of)
4-aminobenzoate 500 MG [Potaba] (SBDC, consists of)
Oral Capsule (DF, has dose form)
Potaba (BN, has ingredient)
4-aminobenzoate 500 MG Oral Capsule (SCD, tradename of)

Linked data

NDCs

00516005110
00516005125

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 202088 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/202088 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 202088. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.